Articles tagged with: ASH 2010 Daily Update
The American Society of Hematology annual meeting was held earlier this month in Orlando. The myelodysplastic syndromes portion of the conference concluded with a poster session on the third evening and a session of talks in the morning of the fourth and final day of the meeting.
Day 3 Poster Session
In the evening, results from a number of clinical trials for current MDS treatments as well as new drugs under development were presented during a poster session.
One study presented during the poster session compared the efficacy of Vidaza …
This year’s American Society of Hematology meeting was held last week in Orlando. The third day of the conference was filled with presentations about myelodysplastic syndromes. There were talks throughout the day and a poster session in the evening. This article will cover the talks from the day, and another article will cover the highlights from the poster session.
The talks began in the morning with a session about molecular profiling as a tool for the diagnosis and prognosis of patients with myelodysplastic syndromes (MDS). Molecular profiling allows the physician …
On December 5, the second full day of the American Society of Hematology meeting, the sessions about myelodysplastic syndromes included a series of talks in the afternoon and a poster session in the evening.
The afternoon session featured presentations about the molecular mechanisms of myelodysplastic syndromes (MDS). Many of the talks were about genes and genetic mutations that play a role in MDS to help physicians better understand the disease and how to target it with treatment.
In the evening, results from a number of clinical trials for current MDS …
This year’s American Society of Hematology meeting took place last week in Orlando. December 4 was the first full day of the conference, and it included several talks as well as a poster session related to myelodysplastic syndromes.
The first myelodysplastic syndromes (MDS)-related event was an education program in the afternoon. The same session was also held Sunday morning.
First, Dr. Guillermo Garcia-Manero from the M.D. Anderson Cancer Center in Houston spoke about prognostic scoring systems for MDS. He said that it is important for physicians to explain …